Why the study?
Anticancer therapies cause cardiotoxic side effects and mitochondrial damage, but data exploring secondary mitochondrial signaling beyond oxidative stress in cardio-oncology remain limited.
Design
Review
Authors
Loading...
Further research needed on mitochondrial epigenetic/ncRNA roles in cardiotoxicity; leaves open therapeutic implications for anticancer therapy patients.
Key points are not available for this paper at this time.
Bikomeye et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: